Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

FDA Approves First Meningococcal Vaccine for Young Children

April 25, 2011 7:40 am | News | Comments

The U.S. Food and Drug Administration approved the use of Menactra in children as young as 9 months for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135.


FDA Posts Positive Review of Boceprevir

April 25, 2011 7:37 am | by Matthew Perrone | News | Comments

Federal health officials said a highly-anticipated drug to treat hepatitis C made by Merck appears to cure more patients in less time than established drugs that have been used for 20 years.


AstraZeneca, Pozen Filing Vimovo Lawsuit

April 25, 2011 7:34 am | News | Comments

Pozen Inc. said that it filed a patent infringement lawsuit against generic drugmaker Dr. Reddy's Laboratories Ltd., which is seeking approval for a generic version of its osteoarthritis drug Vimovo.


Compound Offers Treatment of Adult Shingles

April 22, 2011 7:40 am | News | Comments

Researchers have discovered a compound called L-BHDA that has the potential to be more effective than existing agents in treating the very painful blisters known as shingles.


Drug Effective in Treating Kidney Disease in Diabetic Patients

April 22, 2011 7:37 am | by Debra Kain | News | Comments

Researchers have published promising results of a clinical study using pirfenidone, an experimental anti-fibrotic and anti-inflammatory drug, to treat patients with diabetic nephropathy.


Nanoscale Vaults Encapsulate Nanodisks for Drug Delivery

April 22, 2011 7:33 am | by Jennifer Marcus, UCLA | News | Comments

UCLA researchers have demonstrated the ability to package drug-loaded "nanodisks" into naturally occurring nanoscale capsules that have been engineered for therapeutic drug delivery.


Early Warning System for Alzheimer's Disease

April 22, 2011 7:22 am | News | Comments

Scientists are developing a technique based on a new discovery which could pave the way towards detecting Alzheimer's disease in its earliest stages.


Compound Halts Progression of Multiple Sclerosis

April 22, 2011 7:19 am | News | Comments

Scientists have developed the first of a new class of highly selective compounds that effectively suppresses the severity of multiple sclerosis in animal models.


Researchers Identify Genes Causing Antimalarial Drug Resistance

April 22, 2011 7:17 am | News | Comments

Researchers have identified several genes that may be implicated in the malaria parasite's notorious ability to rapidly evade drug treatments.


Scientists Observe Single Gene Activity in Living Cells

April 22, 2011 7:13 am | News | Comments

Researchers have for the first time observed the activity of a single gene in living cells, following the process of gene transcription.


Pfizer Says Patient Died in Oral RA Drug Study

April 22, 2011 7:04 am | News | Comments

Pfizer Inc. confirmed that one patient who was taking its drug candidate tofacitinib, a pill designed to treat rheumatoid arthritis, died during a recent clinical trial and said the death was connected to the drug.


Halaven Approved in Japan for Inoperable Breast Cancer

April 22, 2011 7:01 am | News | Comments

Eisai Co. has received approval to market its novel anticancer Halaven Injection 1mg (eribulin mesylate) in Japan for the treatment of inoperable and recurrent breast cancer.


Market Approval in Japan for LIXIANA

April 22, 2011 6:59 am | News | Comments

Daiichi Sankyo has received its first marketing approval for LIXIANA 15 mg and 30 mg tablets by the Ministry of Health, Labor and Welfare in Japan.


High Throughput Microplate Imaging

April 22, 2011 6:53 am | Product Releases | Comments

TTP LabTech introduced the Acumen eX3 high content, microplate imaging system, which features a 561nm laser.


Protein Production Reagent

April 22, 2011 6:51 am | Product Releases | Comments

EMD Millipore has launched the NovaCHOice Transfection Kit that accelerates protein production from the suspension Chinese hamster ovary (CHO) cell line.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.